This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Try These ETF Strategies to Play the Market Optimism for 2H21
by Sweta Jaiswal, FRM
Here we discuss certain ETF strategies to help investors gain from the optimism surrounding the expectations of a strong Wall Street run in the second half of 2021.
Momentum ETFs & Stocks to Buy Now
by Sweta Killa
Momentum investing would be a winning strategy for those seeking higher returns in a short spell.
ETF Strategies to Play the Drop in New US COVID-19 Cases
by Sweta Jaiswal, FRM
Here we discuss some ETF strategies that investors can play amid the upbeat outlook for the U.S. market.
New Momentum ETF (QQQA) Hits the Market
by Sweta Jaiswal, FRM
Let's take a detailed look at the ProShares Nasdaq-100 Dorsey Wright Momentum ETF (QQQA) that was recently launched by the house of ProShares.
Top 3 Reasons Why You Should Bet on Momentum ETFs Now
by Sweta Jaiswal, FRM
Investors who want to gain from the steadily recovering U.S. economy can consider momentum ETFs.
Momentum ETFs to Gain From the New Stimulus Optimism
by Sweta Jaiswal, FRM
Here we highlight some momentum ETFs that are lucrative investment picks keeping in mind the optimism surrounding Wall Street.
ETF Investing Areas Looking Attractive After a Blue Wave
by Sweta Jaiswal, FRM
Let's look at some ETF areas that are expected to perform well as Democrats take control of the U.S. Senate.
3 Reasons Setting the Tone Right for Momentum ETFs
by Sweta Jaiswal, FRM
Here we highlight some momentum ETFs that are lucrative investment picks given the current market optimism.
ETF Strategies to Gain From Vaccine Hopes & Biden's Transition
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from the upbeat coronavirus vaccine data amid the health crisis.
Momentum ETFs to Play on Coronavirus Vaccine Hopes
by Sweta Jaiswal, FRM
Here we highlight some momentum ETFs that are lucrative investment picks now on the flowing in of positive news regarding coronavirus vaccine.